Literature DB >> 23536265

Nonculprit coronary plaque characteristics of chronic kidney disease.

Koji Kato1, Taishi Yonetsu, Haibo Jia, Farhad Abtahian, Rocco Vergallo, Sining Hu, Jinwei Tian, Soo-Joong Kim, Hang Lee, Iris McNulty, Stephen Lee, Shiro Uemura, Yangsoo Jang, Seung-Jung Park, Kyoichi Mizuno, Bo Yu, Ik-Kyung Jang.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) promotes the development of atherosclerosis and increases the risk of cardiovascular disease. The aim of the present study was to compare the coronary plaque characteristics of patients with and without CKD using optical coherence tomography. METHODS AND
RESULTS: We identified 463 nonculprit plaques from 287 patients from the Massachusetts General Hospital (MGH) optical coherence tomography registry. CKD was defined as estimated glomerular filtration rate <60 mL/min per 1.73 m(2). A total of 402 plaques (250 patients) were in the non-CKD group and 61 plaques (37 patients) were in the CKD group. Compared with non-CKD plaques, plaques with CKD had a larger lipid index (mean lipid arc×lipid length, 1248.4±782.8 mm° [non-CKD] versus 1716.1±1116.2 mm° [CKD]; P=0.003). Fibrous cap thickness was not significantly different between the groups. Calcification (34.8% [non-CKD] versus 50.8% [CKD]; P=0.041), cholesterol crystals (11.2% [non-CKD] versus 23.0% [CKD]; P=0.048), and plaque disruption (5.5% [non-CKD] versus 13.1% [CKD]; P=0.049) were more frequently observed in the CKD group. In the multivariate linear regression model, a lower estimated glomerular filtration rate and diabetes mellitus were independent risk factors for a larger lipid index.
CONCLUSIONS: Compared with non-CKD patients, the patients with CKD had a larger lipid index with a higher prevalence of calcium, cholesterol crystals, and plaque disruption. The multivariate linear regression model demonstrated that a lower estimated glomerular filtration rate was an independent risk factor for a larger lipid index.

Entities:  

Keywords:  cholesterol crystal; chronic kidney disease; optical coherence tomography; plaque

Mesh:

Substances:

Year:  2013        PMID: 23536265     DOI: 10.1161/CIRCIMAGING.112.000165

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  18 in total

1.  Degree of luminal narrowing and composition of thrombus in plaque erosion.

Authors:  Osamu Kurihara; Masamichi Takano; Tsunenari Soeda; Francesco Fracassi; Makoto Araki; Akihiro Nakajima; Iris McNulty; Hang Lee; Kyoichi Mizuno; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

2.  Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis.

Authors:  Yu Kataoka; Rishi Puri; Muhammad Hammadah; Bhanu Duggal; Kiyoko Uno; Samir R Kapadia; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

3.  Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.

Authors:  Yu Kataoka; Stephen J Nicholls; Jordan Andrews; Kiyoko Uno; Samir R Kapadia; E Murat Tuzcu; Steven E Nissen; Rishi Puri
Journal:  Cardiovasc Diagn Ther       Date:  2022-02

4.  Biomarkers associated with coronary high-risk plaques.

Authors:  Akihiro Nakajima; Peter Libby; Satoru Mitomo; Haruhito Yuki; Makoto Araki; Lena Marie Seegers; Iris McNulty; Hang Lee; Midori Ishibashi; Kazuna Kobayashi; Jouke Dijkstra; Toru Ouchi; Hirokazu Onishi; Hiroto Yabushita; Satoshi Matsuoka; Hiroyoshi Kawamoto; Yusuke Watanabe; Kentaro Tanaka; Shengpu Chou; Tomohiko Sato; Toru Naganuma; Masaaki Okutsu; Satoko Tahara; Naoyuki Kurita; Shotaro Nakamura; David J Kuter; Sunao Nakamura; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2022-10-07       Impact factor: 5.221

Review 5.  Assessment of Coronary Plaque Vulnerability with Optical Coherence Tomography.

Authors:  Shiro Uemura; Tsunenari Soeda; Yu Sugawara; Tomoya Ueda; Makoto Watanabe; Yoshihiko Saito
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

Review 6.  Imaging of coronary atherosclerosis in various susceptible groups.

Authors:  Ravi Kiran Munnur; Nitesh Nerlekar; Dennis T L Wong
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

Review 7.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

8.  Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.

Authors:  Kazuhiro Dan; Toru Miyoshi; Makoto Nakahama; Tomofumi Mizuno; Kenzo Kagawa; Yoichiro Naito; Satoshi Kawada; Hiroshi Ito
Journal:  Cardiorenal Med       Date:  2018-03-27       Impact factor: 2.041

9.  Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study.

Authors:  Sílvia Collado; Elisabeth Coll; Carlos Nicolau; Mercedes Pons; Josep M Cruzado; Julio Pascual; Aleix Cases
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 10.  How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?

Authors:  Hoon Young Choi; Hyeong Cheon Park; Sung Kyu Ha
Journal:  Electrolyte Blood Press       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.